Clonazepam: uses, dosing, side effects & brands

Klonopin, a benzodiazepine, is available as scored tablets with a K-shaped perforation containing 0.5 mg of clonazepam and unscored tablets with a K-shaped perforation containing 1 mg or 2 mg of clonazepam. Each tablet also contains lactose, magnesium stearate, microcrystalline cellulose and corn starch, with the following colorants: 0.5 mg—FD&C Yellow No. 6 Lake; 1 mg—FD&C Blue No. 1 Lake and FD&C Blue No. 2 Lake.

The FDA classifies clonazepam as a benzodiazepine. Benzodiazepines boost the brain's main calming chemical, GABA, by binding to the GABA-A receptor and making its chloride channel open more often. This quiets nerve activity, producing sedation, reduced anxiety, muscle relaxation, and protection against seizures. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.

Clonazepam is a benzodiazepine and CNS depressant, and the label repeatedly addresses alcohol. It states the CNS-depressant action of benzodiazepines may be potentiated by alcohol, and directs that patients be warned about concomitant use of alcohol or other CNS-depressant drugs during therapy. The boxed warning and Abuse/Misuse sections note that benzodiazepine abuse and misuse commonly involve concomitant alcohol, which is associated with an increased frequency of serious adverse outcomes including respiratory depression, overdose, and death; the label advises avoiding or minimizing concomitant use of CNS depressants. This is what clonazepam's FDA label says; alcohol advice depends on your dose and health, so confirm with your pharmacist.

The boxed warning states that continued use may lead to clinically significant physical dependence, and that abrupt discontinuation or rapid dosage reduction after continued use may precipitate acute withdrawal reactions that can be life-threatening (including seizures). Named acute withdrawal signs include anxiety, insomnia, tremor, dizziness, blurred vision, depersonalization/derealization, headache, hypertension, tachycardia, muscle pain, and gastrointestinal effects; more severe reactions can include catatonia, convulsions, delirium tremens, hallucinations, psychosis, and suicidality. A protracted withdrawal syndrome lasting weeks to more than 12 months is also described. To reduce this risk, the label directs the prescriber to use a gradual, patient-specific taper to discontinue or reduce the dose, and if withdrawal reactions occur, to pause the taper or return to the prior dose and then decrease more slowly. Risk is higher with higher doses and longer duration of use. Do not stop clonazepam on your own — any change is a prescriber-managed decision.

The elimination half-life of clonazepam is about 30 to 40 hours — that is how long the body takes to clear half of a dose. This is the parent drug's elimination half-life in healthy adults; the label states clonazepam's pharmacokinetics are dose-independent. The label does not assign a materially longer half-life to any active metabolite, though it does not explicitly characterize metabolites as inactive. Actual half-life varies with age, liver function, and other factors. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run clonazepam against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

We track 2 clonazepam-containing products in the U.S.: Clonazepam and Klonopin. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

Across the brands we track, clonazepam is currently marketed as tablet and tablet, orally disintegrating, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Yes. Our catalog lists 1 generic clonazepam product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

The FDA's Enforcement database lists at least 5 recall records whose product description mentions clonazepam. The most recent: Clonazepam Orally Disintegrating Tablets (Nov 18, 2024). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.

Alcohol: the FDA label says to avoid alcohol — see the alcohol section above for what it actually says. This is what the FDA label and our cited sources say — it is not a complete list. Your pharmacist can check your own combination.

"In your system" means two different things. The first is how long the drug is still acting and clearing from your blood. Clonazepam has an elimination half-life of about 30 to 40 hours (per the FDA KLONOPIN label), and a drug is considered largely cleared after roughly 4 to 5 half-lives — so for clonazepam that works out to about 5 to 8 days for most of the drug to leave the body. The second meaning is how long a drug test can still detect it, which is longer than the clearance time and depends entirely on the test type (urine, blood, saliva, or hair) and how much and how long the drug was taken. These are approximate ranges from laboratory references, not guarantees; only a clinician or testing lab can interpret a specific result.

Urine is the most common test. As a long-acting benzodiazepine, clonazepam is typically detectable in urine for about 1 to 9 days after the last dose for typical use; with chronic or higher-dose use, its metabolites can sometimes be detected for up to about two weeks or even a month, per Biology Insights. One important and often-missed point: standard benzodiazepine immunoassay screens are calibrated to metabolites of older benzodiazepines (like oxazepam and nordiazepam) and cross-react poorly with clonazepam, lorazepam, and alprazolam — the University of Rochester Medical Center states that "alprazolam, clonazepam, temazepam, and triazolam may not be found in many of the common tests." This means a routine screen can return a false negative even when the drug is present; labs confirm clonazepam specifically by targeting its metabolite 7-aminoclonazepam with LC-MS/MS. The exact window also depends on dose, duration and frequency of use, individual metabolism, hydration, and the specific assay cutoff. These are approximate ranges; only the testing lab can interpret a given result.

Blood and saliva have much shorter windows than urine because they reflect recent use. In blood, clonazepam is typically detectable for up to about 72 hours (roughly 1 to 3 days) after the last dose. In saliva (oral fluid), it is generally detectable for about 5 to 6 days. Hair testing has by far the longest window: clonazepam and its metabolites can typically be detected for up to about 90 days, reflecting a roughly three-month history of use, though hair tests usually cannot pick up use from the last few days. All of these are approximate ranges from laboratory references, not guarantees, and only a clinician or testing lab can interpret a specific result.

Several factors shift the numbers. Dose and frequency matter most: a single dose clears faster than chronic daily use, which lets the drug and its metabolites accumulate and extends the detection window. Metabolism plays a large role — age, and liver and kidney function affect how quickly clonazepam is broken down and eliminated, so older adults or people with impaired liver or kidney function may retain it longer. Body composition and hydration can also influence measured concentrations, and the test itself matters: each assay has its own cutoff threshold and sensitivity, and standard immunoassays detect clonazepam poorly compared with confirmatory LC-MS/MS. Because of all this variability, these are approximate ranges from laboratory references, not guarantees. Only a clinician or testing lab can interpret a specific result, and you should never stop a prescribed medication without talking to the prescriber who ordered it.